I-Score: Intensive Stroke Cycling for Optimal Recovery and Economic Value

ConditionStroke
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorThe Cleveland Clinic

About this trial

Traditional rehabilitation approaches are time and personnel intensive and costly, and leave \~75% of stroke survivors with residual disability. We propose a clinical trial to determine effects of forced aerobic exercise (FE; i.e., mechanically supplemented) in facilitating upper and lower extremity motor recovery post-stroke in an outpatient rehabilitation setting, to elucidate neural and biochemical substrates of FE-induced motor recovery, and to evaluate cost effectiveness of a FE-centered intervention compared to traditional stroke rehabilitation. The global effect of FE has the potential to enhance recovery in a growing population of stroke survivors in a cost-effective manner, thus accelerating its clinical acceptance.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

3-9 months following single ischemic or hemorrhagic stroke confirmed with neuroimaging (ie: first-time stroke)

Fugl-Meyer motor score 19-55 in the involved UE

Fugl-Meyer score <34 in the involved LE demonstrating residual hemiparesis

Ambulatory ≥ 20 meters with no more than contact guard assistance

Disqualifiers

hospitalization for myocardial infarction, heart failure or heart surgery within 3 months

cardiac arrhythmia

hypertrophic cardiomyopathy

history of multiple strokes

Trial design

Design model

Parallel

Treatments tested in this trial

  • Forced Rate Exercise + Rehab

    Behavioral

    The FE+rehab group (N=33) will complete FE on the cycle designed to augment pedaling rate to \>75 RPM. Target heart rate zone will be set to 60-80% of HR reserve. The session will consist of a 5-min warm-up, 35-min main exercise set, and 5-min cool down. Following FE, abbreviated sessions of motor learning-based training will be administered by a neurologic OT and PT experienced in stroke rehabilitation, with 30 min focused on restoration of UE function (OT) and 15 min focused on LE motor function/ gait training (PT).

  • Rehabilitation

    Behavioral

    The rehab group will receive consecutive, full-length sessions of motor learning-based training, administered by a neurologic OT and PT experienced in stroke rehabilitation, with 45 min focused on restoration of UE function (OT) and 45 min focused on LE motor function/ gait training (PT).

Treatment groups

66 Participants
are divided into 2 treatment groups
Group A: Forced Rate Exercise + RehabilitationActive comparator 1 intervention
Group B: RehabilitationActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Upper Extremity Fugl-Meyer Motor Assessment

Impairment-based measure of the upper extremity post-stroke.

Time frame
Baseline to end of treatment at 12 weeks and end of treatment + 6 months
2

Gait Velocity

Gait velocity obtained using motion capture.

Time frame
Baseline to end of treatment at 12 weeks and end of treatment + 6 months
3

Plasma IGF-1

Blood biomarker for neuroplasticity

Time frame
Before and after first and 24th treatment session
4

Serum BDNF

Blood biomarker for neuroplasticity

Time frame
Before and after first and 24th treatment session

Secondary outcomes

1

Action Research Arm Test

Measure of upper extremity gross and fine motor function post-stroke

Time frame
Baseline to end of treatment at 12 weeks and end of treatment + 6 months
2

Biomechanical Dexterity Task

Force tracking task - accuracy within targeted range

Time frame
Baseline to end of treatment at 12 weeks and end of treatment + 6 months
3

Biomechanical measure of maximum grasp force

maximum grasp force measured with force transducer

Time frame
Baseline to end of treatment at 12 weeks and end of treatment + 6 months
4

Bimanual Dexterity Task

Time to complete task when separating 2 force transducers

Time frame
Baseline to end of treatment at 12 weeks and end of treatment + 6 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.